Personalized diabetes care for seniors: simple assessment may reduce harm

NCT ID NCT06469437

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving doctors a geriatric assessment—a quick check of frailty and function—helps them set safer blood sugar goals for patients aged 60+ with type 2 diabetes. 220 participants will be randomly assigned to usual care or to have their doctor receive the assessment results. The researchers will then check if treatment plans better match each patient's needs and track outcomes like hypoglycemia, falls, and hospitalizations over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
geriatric assessment
What this could lead to
If successful, this could provide a practical tool for doctors to personalize diabetes treatment for older adults, potentially reducing hypoglycemia, falls, and hospitalizations.
What could go wrong
This is a relatively small, early-stage trial focused on process improvement, not a direct treatment. The results may not apply to all settings, and the intervention may not lead to better health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRAIL ELDERLY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital de Clínicas de Porto Alegre

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 91755678, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.